Mutant envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein

Oncogene

Volumn 19, Issue 5, 2000, Pages 599-607

  Epinat, Jean Charles ^a   Kazandjian, Dickran ^a   Harkness, Daniel D ^a   Petros, Steven ^a   Dave, Jasmine ^a   White, David W ^a,b   Gilmore, Thomas D ^a  

^a Boston University   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

Envelope sequences; Malignant transformation; NF B; Retroviral oncogene; Transcription factor; v Rel

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MUTANT PROTEIN; ONCOPROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CHICKEN; CONTROLLED STUDY; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; TRANSACTIVATION; VIRUS ONCOGENE; YEAST;

ANIMALIA; AVES; GALLUS GALLUS; RNA VIRUSES;

EID: 0034598788     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203376     Document Type: Article

References (36)

1. Barkett M and Gilmore TD. (1999). Oncogene Rev., 18, 6910-6924.
2. Bhat GV and Temin HM. (1990). Oncogene, 5, 625-634,
3. Capobianco AJ, Simmons DL and Gilmore TD. (1990). Oncogene, 5, 257-265.
4. Chang C-C, Zhang J, Lombardi L, Neri A and Dalla-Favera R. (1995). Mol. Cell. Biol., 15, 5180-5187.
5. Chen C, Angès F and Gélinas C. (1999) Mol. Cell. Biol., 19, 307-316.
6. Curristin SM, Bird KJ, Tubbs RJ and Ruddell A. (1997). J. Virol., 71, 5972-5981.
7. Fujita T, Nolan GP, Ghosh S and Baltimore D. (1992). Genes Dev., 6, 775-787.
8. Garson K, Percival H and Kang CY. (1990). Virology, 177, 106-115.
9. Ghosh S, May MJ and Kopp EB. (1998). Annu. Rev. Immunol., 16, 225-260.
10. Gilmore TD. (1999). Oncogene Rev., 18, 6925-6937.
11. Guarente L and Ptashne M. (1981). Proc. Natl. Acad. Sci. USA, 78, 2199-2203.
12. Guarente L, Yocum RR and Gifford P. (1982). Proc. Natl. Acad. Sci. USA, 79, 7410-7414.
13. Hrdliĉková R, Nehyba J and Humphries EH. (1994). J. Virol., 68, 2371-2382.
14. Kamens J and Brent R. (1991). New Biol., 3, 1005-1013.
15. Kamens J, Richardson P, Mosialos G, Brent R and Gilmore TD. (1990). Mol. Cell. Biol., 10, 2840-2847.
16. Kralova J, Schatzle JD, Bargmann W and Bose Jr HR. (1994). J. Virol., 68, 2073-2083.
17. Lillie JW and Green MR. (1989). Nature, 338, 39-44.
18. Morin PJ, Subramanian GS and Gilmore TD. (1993). Nucleic Acids Res., 21, 2157-2163.
19. Mosialos G and Gilmore TD. (1993). Oncogene, 8, 721-730.
20. Nehyba J, Hrdliĉková R and Bose Jr HR. (1997). Oncogene, 14, 2881-2897.
21. Pierce JW, Lenardo M and Baltimore D. (1988). Proc. Natl. Acad. Sci. USA, 85, 1482-1486.
22. Rayet B and Gélinas C. (1999). Oncogene, 18, 6938-6947.
23. Rice NR and Gilden RV. (1988). In: The Oncogene Handbook. Reddy EP, Skalka AM and Curran T. (eds). Elsevier Science Publishers: New York, pp. 495-512.
24. Richardson PM and Gilmore TD. (1991). J. Virol., 65, 3122-3130.
25. Sachdev S and Hannink M. (1998). Mol. Cell. Biol., 18, 5445-5456.
26. Sadowski I and Ptashne M. (1989). Nucleic Acids Res., 17, 7539.
27. Sambrook J, Fritsch EF and Maniatis T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
28. Sarkar S and Gilmore TD. (1993). Oncogene, 8, 2245-2252.
29. Sif S, Capobianco AJ and Gilmore TD. (1993). Oncogene, 8, 2501-2509.
30. Sif S and Gilmore TD. (1994). J. Virol., 68, 7131-7138.
31. Smardova J, Walker A, Morrison LE, Kabrun N and Enrietto P. (1995). Oncogene, 10, 2017-2026.
32. Thakur S, Lin H-C, Tseng W-T, Kumar S, Bravo R, Foss F, Gélinas C and Rabson AB. (1994). Oncogene, 9, 2335-2344.
33. Wang Y, Dooher JE, Koedood Zhao M and Gilmore TD. (1999). Gene, 234, 403-409.
34. White DW, Pitoc GA and Gilmore TD. (1996). Mol. Cell. Biol., 16, 1169-1178.
35. Wilhelmsen KC, Eggleton K and Temin HM. (1984). J. Virol., 52, 172-182.
36. Xu X and Gélinas C. (1997). Oncogene, 14, 1521-1530.